LD-2 disclosure · 4th Quarter - Report
DYNAVAX TECHNOLOGIES CORP.
via DYNAVAX TECHNOLOGIES CORP.
Expenses$50Kself-filed spend
Client
- Name
- DYNAVAX TECHNOLOGIES CORP.
- Location
- California · United States of America
Registrant
- Firm
- DYNAVAX TECHNOLOGIES CORP.
- Description
- Biopharmaceutical company focused on developing and commercializing novel vaccines.
- Location
- Emeryville, California, United States of America
Lobbying activities
1 issueHealth Issues
Issues related to vaccine policy
LobbyistsKATHY KULKARNI
Covered position (KATHY KULKARNI): Health Policy Aide/Legislative - Office of Congressman Frank Pallone Jr.
TargetedState, Dept of (DOS)